{"id":446840,"title":"Consultation Notice: Health Canada Requests Feedback on Potential Impacts and Uses if Company Names were added to the Generic Submissions Under Review List - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:58:18.072000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/notice-company-names-generic-submissions-under-review.html?wbdisable=false","snippet":"Consultation Notice: Health Canada Requests Feedback on Potential Impacts and Uses if Company Names were added to the Generic Submissions Under Review List January 7, 2019 Our file number: 18-121970-181 As a regulator, Health Canada plays an important role in protecting the…","rawSnapshotUrl":"/api/snapshots/raw/446840","browseUrl":"https://replay.healtharchive.ca/job-6/20260103125818/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/notice-company-names-generic-submissions-under-review.html?wbdisable=false#ha_snapshot=446840","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}